Orphanet: Ricerca semplice
x

Cerca una sperimentazione clinica

* (*) campo obbligatorio

185 Risultato/i

Ordinato per

Sperimentazione in fase di reclutamento = Sperimentazione in fase di reclutamento
; Sperimentazione in corso = Sperimentazione in corso
; Finanziato da un ente associato a IRDiRC =

Sperimentazioni cliniche nazionali

BELGIO

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Sperimentazione in fase di reclutamento
Sperimentazione in corso
MACRODUCT-3710: Efficacy of a New Sweat Collection Support: Impact on Neonatal Screening and Early Treatment of Cystic Fibrosis
Université Catholique de Louvain (UCL)
Louvain centre for Toxicology and Applied Pharmacology

FRANCIA

HAUTS-DE-FRANCE
AMIENS

Sperimentazione in fase di reclutamento
Sperimentazione in corso
Efficacy of Clarithromycin or Moxifloxacin Containing Regimen in 6 Months Sputum Conversion of Mycobacterium Xenopi
CHU Amiens-Picardie - Site Sud
Service de Pneumologie et réanimation respiratoire

GERMANIA

Berlin
BERLIN

Sperimentazione in fase di reclutamento
Sperimentazione in corso
A Phase 2, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 in Cystic Fibrosis - DE
Otto-Heubner-Centrum für Kinder- und Jugendmedizin
Klinik für Pädiatrie mit Schwerpunkt Pneumologie und Immunologie

GERMANIA

Hessen
FRANKFURT AM MAIN

Sperimentazione in fase di reclutamento
Sperimentazione in corso
A Phase 2, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 in Cystic Fibrosis - DE
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt
Pädiatrische Allergologie, Pneumologie und Mukoviszidose

GERMANIA

Thüringen
JENA

Sperimentazione in fase di reclutamento
Sperimentazione in corso
Finanziato da un ente associato a IRDiRCA Phase 3 Efficacy and Safety Study of Ataluren (PTC124®) in Patients With Nonsense Mutation Cystic Fibrosis - DE - Completed
Universitätsklinikum Jena
Klinik für Kinder- und Jugendmedizin: Pneumologie / Mukoviszidosezentrum

PAESI BASSI

Utrecht
UTRECHT

Sperimentazione in corso
Finanziato da un ente associato a IRDiRCThe TRIO study: Genistein as an add-on treatment for CF?
UMC Utrecht - Universitair Medisch Centrum Utrecht
Afdeling Longziekten voor kinderen

REGNO UNITO; GRAN BRETAGNA

Avon
BRISTOL

Sperimentazione in fase di reclutamento
Sperimentazione in corso
Torpedo-CF: Trial of optimal therapy for pseudomonas eradication in cystic fibrosis (Phase IV)
Bristol Royal Hospital for Children
Department of Cystic Fibrosis and Respiratory Medicine

REGNO UNITO; GRAN BRETAGNA

Cambridgeshire
CAMBRIDGE

REGNO UNITO; GRAN BRETAGNA

Grampian
ABERDEEN

REGNO UNITO; GRAN BRETAGNA

Greater London
LONDON

REGNO UNITO; GRAN BRETAGNA

Greater London
LONDON

REGNO UNITO; GRAN BRETAGNA

Hampshire
SOUTHAMPTON

REGNO UNITO; GRAN BRETAGNA

Merseyside
LIVERPOOL

REGNO UNITO; GRAN BRETAGNA

Merseyside
LIVERPOOL

REGNO UNITO; GRAN BRETAGNA

Nottinghamshire
NOTTINGHAM

REGNO UNITO; GRAN BRETAGNA

West Midlands
BIRMINGHAM

SPAGNA

Cataluña
SABADELL

FRANCIA

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Sperimentazione in fase di reclutamento
Sperimentazione in corso
ProCoCo: Procollagen-3 Driven Corticosteroids for Persistent Acute Respiratory Distress Syndrome
CHU de Marseille - Hôpital Nord
Service de réanimation médicale détresses respiratoires - Infections sévères

GERMANIA

Baden-Württemberg
FREIBURG

Sperimentazione in fase di reclutamento
Sperimentazione in corso
ABASARC: Safety and efficacy of Abatacept in patients with treatment-resistant sarcoidosis
Klinik für Pneumologie am Universitätsklinikum Freiburg
Klinik für Pneumologie

GERMANIA

Baden-Württemberg
HEIDELBERG

GERMANIA

Nordrhein-Westfalen
ESSEN

GERMANIA

Schleswig-Holstein
LÜBECK

Sperimentazione in corso
IMPALA-X: An Open-label, Non-controlled, Multicentre Clinical Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis Patients -DE-
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
Medizinische Klinik III - Pneumologie, Infektiologie

REGNO UNITO; GRAN BRETAGNA

Greater London
LONDON

REGNO UNITO; GRAN BRETAGNA

Greater Manchester
ADDRESS: NOT PROVIDED - UK

REGNO UNITO; GRAN BRETAGNA

Norfolk
NORWICH

FRANCIA

ILE-DE-FRANCE
PARIS

Sperimentazione in fase di reclutamento
Sperimentazione in corso
EXAFIP : Cyclophosphamide Added to Corticosteroid in the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis: a Placebo-controlled Randomized Trial (Phase III)
Groupe hospitalier AP-HP.6 - Hôpital Tenon
Unité Pneumologie - Oncologie Thoracique - Maladies Pulmonaires Rares

GERMANIA

Hessen
GIEßEN

Sperimentazione in corso
An open-label extension trial of the long term safety of oral BIBF 1120 in patients with Idiopathic Pulmonary Fibrosis (Phase III) - DE
Med. Klinik und Poliklinik II des UKGM am Standort Gießen
Schwerpunkt Pneumologie und Intensivmedizin - Fibrosierende Lungenerkrankungen

GERMANIA

Nordrhein-Westfalen
ESSEN

REGNO UNITO; GRAN BRETAGNA

Greater Manchester
ADDRESS: NOT PROVIDED - UK

REGNO UNITO; GRAN BRETAGNA

Greater Manchester
ADDRESS: NOT PROVIDED - UK

REGNO UNITO; GRAN BRETAGNA

Norfolk
NORWICH

REGNO UNITO; GRAN BRETAGNA

Nottinghamshire
NOTTINGHAM

Sperimentazioni cliniche internazionali

IRLANDA

County Cork
CORK

Finanziato da un ente associato a IRDiRCCFMATTERS: Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified
University College Cork
UNIVERSITY COLLEGE CORK, NATIONAL UNIVERSITY OF IRELAND

REGNO UNITO; GRAN BRETAGNA

Greater London
LONDON

DeVENT: Decision Support System to Evaluate VENTilation in ARDS (acute respiratory distress syndrome)
Imperial College London, main campus
Imperial College London Headquarters